Synonyms:tobramycin, 32986-56-4, Nebramycin 6, Nebramycin factor 6, 3'-Deoxykanamycin B, Tobramicin, Nebcin, Tobi, Aktob, Tobrex, Tobramycin Base, Deoxykanamycin B, Tobi Podhaler, Nebramycin VI, Bethkis, Tobradistin, NEBRAMYCIN, C18H37N5O9, Tobralex, UNII-VZ8RRZ51VK, Tobracin (TN), NSC 180514, Tobrex (TN), VZ8RRZ51VK, (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol, Obramycin, CHEBI:28864, 1-Epitobramycin, vantobra, Tobramicina, Tobramycine, Tobramycinum, Gotabiotic, Nebicin, Tobacin, Tobrased, (1S,2S,3R,4S,6R)-4,6-diamino-3-[(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside, Kitabis Pak, Tobramycine [INN-French], Tobramycinum [INN-Latin], Tobramicina [INN-Spanish], (2S,3R,4S,5S,6R)-4-amino-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol, O-3-Amino-3-deoxy-?-D-glucopyranosyl-(1-6)-O-[2,6-diamino-2,3,6-trideoxy-?-D-ribohexopyranosyl-(1-4)]-2-deoxy-D-streptamine, O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine, TOY, Nebramycin factir 6, HSDB 3259, SR-05000001726, EINECS 251-322-5, SPRC-AB01, BRN 1357507, torbamycin, Kitabis, NSC-180514, tobramycin solution for inhalation, Tobramycin,(S), Nebcin (Sulfate), NCGC00016814-01, (2S,3R,4S,5S,6R)-4-amino-2-((1S,2S,3R,4S,6R)-4,6-diamino-3-((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yloxy)-2-hydroxycyclohexyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol, Bethkis (TN), CAS-32986-56-4, MFCD00077885, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-4))-2-deoxy-, Tobramycin [2M+H], Tobramycin [USAN:USP:INN:BAN:JAN], Tobi (TN), Spectrum_001072, Prestwick3_000544, Spectrum2_000078, Spectrum3_000588, Spectrum4_000752, Spectrum5_001038, DSSTox_CID_3680, Tobramycin (JP17/USP), SCHEMBL2838, CHEMBL1747, DSSTox_RID_77144, DSSTox_GSID_23680, BSPBio_000587, BSPBio_002036, KBioGR_001104, KBioSS_001552, 4-(2,6-Diamino-2,3,6-trideoxy-alpha-D-glycopyranosyl)-6-(3-amino-3-deoxy-alpha-D-glycopyranosyl)-2-deoxystreptamine, MLS000069544, O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine, Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-tyrideoxy-alpha-D-ribohexopyranosyl-(1-6))-2-deoxy-, D-, BIDD:GT0503, SPECTRUM1500579, SPBio_000295, BPBio1_000647, DTXSID8023680, GTPL10930, KBio2_001552, KBio2_004120, KBio2_006688, KBio3_001536, AOB5629, HMS2090B16, HMS2092M17, HMS2096N09
Pubchem:PUBCHEM:129009857
Id:c4891c8f-e5d2-5453-961c-ca44ebd4bf5f
Description:nan
